Fedor Nikulenkov, Ph.D.
Researcher, Lumír Krejčí Research Group
Office: bldg. B07/307
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7365 |
---|---|
E‑mail: |
Total number of publications: 17
2023
-
MUS81 cleaves TOP1‑derived lesions and other DNA-protein cross‑links
BMC Biology, year: 2023, volume: 21, edition: 1, DOI
-
Substituted aminothiazoles as inhibitors of nucleases
Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11584742, year: 2023
-
Substituted aminothiazoles as inhibitors of nucleases
Publisher: Israel Patent Office, state: Israel, patent's number: IL277866, year: 2023
2022
-
Substituted aminothiazoles as inhibitors of nucleases
Publisher: IP Australia, state: Australia, patent's number: AU2019256670, year: 2022
-
Substituted propanamides as inhibitors of nucleases
Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11453663, year: 2022
-
Substituted propanamides as inhibitors of nucleases
Publisher: IP Australia, state: Australia, patent's number: AU2019256672, year: 2022
-
ヌクレアーゼの阻害剤としての置換アミノチアゾール
Publisher: Japan Patent Office (JPO), state: Japan, patent's number: JP7175031, year: 2022
-
ヌクレアーゼの阻害剤としての置換プロパンアミド
Publisher: Japan Patent office, state: Japan, patent's number: JP7148999, year: 2022
2021
-
SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES
Publisher: European Patent Office, state: Germany, patent's number: EP3556755B1, year: 2021
2020
-
Substituted propanamides as inhibitors of nucleases
Publisher: European Patent Office, state: Germany, patent's number: EP3556756, year: 2020